Shenlian Biotech announced that the total shareholding ratio of the company's controlling shareholders and actual controllers Nie Dongsheng, Yang Yufang, Yang Congzhou, and Wang Dongliang was adjusted from 35.82% to 30.78%, which involved a change in equity of 5.04%. This change in equity was due to a change in the company's shareholders' executive partner and the termination of the shareholders' concerted action relationship, and there was no change in the number of shares held by each shareholder.

Shenlian Biotech announced that the total shareholding ratio of the company's controlling shareholders and actual controllers Nie Dongsheng, Yang Yufang, Yang Congzhou, and Wang Dongliang was adjusted from 35.82% to 30.78%, which involved a change in equity of 5.04%. This change in equity was due to a change in the company's shareholders' executive partner and the termination of the shareholders' concerted action relationship, and there was no change in the number of shares held by each shareholder.